Léková politika v České republice a využití farmakoekonomiky

Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F46747885%3A24310%2F07%3A%400190265" target="_blank" >RIV/46747885:24310/07:@0190265 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—

Jazyk výsledku
angličtina
Název v původním jazyce
Drug policy in the Czech Republic and utilization of pharmacoeconomics
Popis výsledku v původním jazyce
Total cost of healthcare in Czech Republic is annually increasing and drug expenditures represent 26 % of total public expenditures spent on healthcare. Drug policy as a part of national healthcare policy is significant factor which has an impact on efficiency of whole healthcare system. It is advisable to use pharmacoeconomics in a process of creating drug policy. Pharmacoeconomics is a relatively recent science which furnishes groundwork for the rational use of drugs thereby searching for reserves inthe allocation of scarce resources.
Název v anglickém jazyce
Drug policy in the Czech Republic and utilization of pharmacoeconomics
Popis výsledku anglicky
Total cost of healthcare in Czech Republic is annually increasing and drug expenditures represent 26 % of total public expenditures spent on healthcare. Drug policy as a part of national healthcare policy is significant factor which has an impact on efficiency of whole healthcare system. It is advisable to use pharmacoeconomics in a process of creating drug policy. Pharmacoeconomics is a relatively recent science which furnishes groundwork for the rational use of drugs thereby searching for reserves inthe allocation of scarce resources.

Rok uplatnění
2007
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Podobné výsledky(10)